Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Alessia Villani, Massimiliano Scalvenzi, Giuseppe Micali, Francesco Lacarrubba, Lucia Genco, Angelo Ruggiero, Luigi Fornaro, Gianluca Guerrasio & Luca Potestio. (2023) Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation. Expert Opinion on Drug Safety 22:7, pages 525-531.
Read now
Read now
Alessia Villani, Eleonora Cinelli, Gabriella Fabbrocini, Aimilios Lallas & Massimiliano Scalvenzi. (2020) Hedgehog inhibitors in the treatment of advanced basal cell carcinoma: risks and benefits. Expert Opinion on Drug Safety 19:12, pages 1585-1594.
Read now
Read now
Articles from other publishers (11)
Gilbert Youssef, Patrick Y. Wen & Eudocia Q. Lee. 2022. Neurological Complications of Systemic Cancer and Antineoplastic Therapy. Neurological Complications of Systemic Cancer and Antineoplastic Therapy
479
500
.
John T. Lear, Reinhard Dummer & Alexander Guminski. (2021) Using drug scheduling to manage adverse events associated with hedgehog pathway inhibitors for basal cell carcinoma. Oncotarget 12:26, pages 2531-2540.
Crossref
Crossref
Alessia Villani, Gabriella Fabbrocini, Claudia Costa & Massimiliano Scalvenzi. (2020) Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma. Dermatology and Therapy 10:3, pages 401-412.
Crossref
Crossref
Y. Qin, D. Long, X. Zhu, Z. Zhou, H. Chai & C. Zhao. (2020) Synthesis, Crystal Structure, and DFT Study of a New Compound 6-(2-Fluorophenyl)-N-(p-Tolyl)Imidazo[1,2-A]Pyridine-2-Carboxamide. Journal of Structural Chemistry 60:12, pages 1917-1924.
Crossref
Crossref
Clio Dessinioti, Mikaella Plaka, Efthymia Soura, Despoina Mortaki, George Papaxoinis, Helen Gogas & Alexander J. Stratigos. (2019) A Practical Guide for the Follow-Up of Patients with Advanced Basal Cell Carcinoma During Treatment with Hedgehog Pathway Inhibitors. The Oncologist 24:8, pages e755-e764.
Crossref
Crossref
Manuel Ruiz-Borrego, Begoña Jimenez, Silvia Antolín, Jose A. García-Saenz, Jesús Corral, Yolanda Jerez, José Trigo, Ander Urruticoechea, Helena Colom, Nuria Gonzalo, Carmen Muñoz, Sara Benito, Rosalía Caballero, Susana Bezares, Eva Carrasco, Federico Rojo & Miguel Martín. (2018) A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012–12 (EDALINE) study. Investigational New Drugs 37:1, pages 98-108.
Crossref
Crossref
Felicite Noubissi, Clement Yedjou, Vladimir Spiegelman & Paul Tchounwou. (2018) Cross-Talk between Wnt and Hh Signaling Pathways in the Pathology of Basal Cell Carcinoma. International Journal of Environmental Research and Public Health 15:7, pages 1442.
Crossref
Crossref
Alicia M Zukas & David Schiff. (2018) Neurological complications of new chemotherapy agents. Neuro-Oncology 20:1, pages 24-36.
Crossref
Crossref
Sherri Y. Huang & Jer-Yen Yang. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
347
359
.
Shauna Higgins, Maggie Chow & Ashley Wysong. 2018. A Practical Guide to Skin Cancer. A Practical Guide to Skin Cancer
35
68
.
Georgi Tchernev, Ivan Pidakev, Ilia Lozev, Torello Lotti & Uwe Wollina. (2017) Multiple nonsyndromic acquired basal cell carcinomas. Wiener Medizinische Wochenschrift 167:5-6, pages 134-138.
Crossref
Crossref